Jett, J R <br/><br/>
Measurable or assessable disease in lung cancer trials: does it matter?  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Dec 1994 
 - 2677-81 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1994.12.12.2677  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Clinical Trials, Phase III as Topic--methods<br/>Confidence Intervals<br/>Female<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Multivariate Analysis<br/>Neoplasm Staging<br/>Prospective Studies<br/>Survival Rate<br/>Treatment Outcome